Targeting inflammation with collagen-binding antibodies
2019; Nature Portfolio; Volume: 16; Issue: 1 Linguagem: Inglês
10.1038/s41584-019-0350-3
ISSN1759-4804
Autores Tópico(s)Rheumatoid Arthritis Research and Therapies
ResumoThe global COVID-19 pandemic has the potential to severely affect those with rheumatic diseases or who are taking immunosuppressive therapies Information is lacking as to how these groups will fare if they become infected A global alliance has rapidly formed to try to address this information deficit
Referência(s)